Author:
Aisa Y.,Mori T.,Nakazato T.,Suzuki S.,Suzuki N.,Ikeda Y.,Okamoto S.
Subject
Infectious Diseases,Transplantation
Reference23 articles.
1. 1. Curtis RE , Travis LB , Rowlings PA , et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208-2216.
2. 2. Weinstock DM , Ambrossi GG , Brennan C , Kiehn TE , Jakubowski A. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development. Bone Marrow Transplant 2006; 37: 539-546.
3. 3. Brunstein CG , Weisdorf DJ , DeFor T , et al. Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation. Blood 2006; 108: 2874-2880.
4. 4. Sundin M , Le Blanc K , Ringdén O , et al. The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation. Haematologica 2006; 91: 1059-1067.
5. 5. Juvonen E , Aalto SM , Tarkkanen J , et al. High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment. Bone Marrow Transplant 2003; 32: 97-102.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献